Lionetti L, Mollica M P, Lombardi A, Cavaliere G, Gifuni G, Barletta A
Department of Biological Sciences, Section of Physiology, University of Naples Federico II, Via Mezzocannone 8, 80134 Naples, Italy.
Nutr Metab Cardiovasc Dis. 2009 Feb;19(2):146-52. doi: 10.1016/j.numecd.2008.10.010. Epub 2009 Jan 25.
We analyze how the inflammatory state in adipose tissue caused by a condition of chronically positive energy balance can lead to insulin resistance first in adipose tissue, then in all insulin-sensitive tissues.
Chronic nutrient overload causes an increase in adipose depots that, if adipose tissue expandability is low, are characterized by an increased presence of hypertrophic adipocytes. This adipocyte hypertrophy is a possible stress condition for the endoplasmic reticulum (ER) that would lead to a proinflammatory state in adipose tissue. In this condition, ER stress would activate metabolic pathways that trigger insulin resistance, release of macrophage chemoattractant proteins, and in chronic inflammation, the death of the hypertrophic adipocyte. The infiltrated macrophages in turn release inflammatory proteins causing further recruitment of macrophages to adipose tissue and the release of inflammatory cytokines. Following these events, insulin resistance becomes extended to all adipose tissue. Insulin-resistant adipocytes, characterized by low liposynthetic capacity and high lipolytic capacity, cause increased release of free fatty acids (FFA). FFA released by lipolitic adipocytes may also activate Toll-like receptors 4 and then chemokines and cytokines release amplifying insulin resistance, lipolysis and inflammation in all adipose tissue. Moreover, increased circulating FFA levels, reduced circulating adiponectin levels and leptin resistance lead to decreased lipid oxidation in non-adipose tissues, thereby triggering ectopic accumulation of lipids, lipotoxicity and insulin resistance.
All the conditions that increase circulating fatty acids and cause lipid overloading (obesity, lipoatrophy, lipodystrophy, catabolic states, etc.) induce a lipotoxic state in non-adipose tissues that gives rise to insulin resistance.
我们分析由长期正能量平衡状态引起的脂肪组织炎症状态如何首先导致脂肪组织内的胰岛素抵抗,进而导致所有胰岛素敏感组织出现胰岛素抵抗。
慢性营养过剩导致脂肪储存增加,如果脂肪组织的扩张能力较低,则其特征是肥大脂肪细胞的数量增加。这种脂肪细胞肥大对内质网(ER)来说可能是一种应激状态,会导致脂肪组织出现促炎状态。在这种情况下,内质网应激会激活引发胰岛素抵抗、巨噬细胞趋化蛋白释放的代谢途径,以及在慢性炎症中导致肥大脂肪细胞死亡的代谢途径。浸润的巨噬细胞反过来释放炎症蛋白,导致更多巨噬细胞被招募到脂肪组织,并释放炎症细胞因子。在这些事件之后,胰岛素抵抗会扩展到所有脂肪组织。具有低脂肪合成能力和高脂肪分解能力特征的胰岛素抵抗脂肪细胞会导致游离脂肪酸(FFA)释放增加。脂肪分解性脂肪细胞释放的游离脂肪酸还可能激活Toll样受体4,进而放大胰岛素抵抗、脂肪分解和所有脂肪组织炎症的趋化因子和细胞因子释放。此外,循环游离脂肪酸水平升高、循环脂联素水平降低和瘦素抵抗会导致非脂肪组织中的脂质氧化减少,从而引发脂质异位积聚、脂毒性和胰岛素抵抗。
所有增加循环脂肪酸并导致脂质过载的情况(肥胖、脂肪萎缩、脂肪营养不良、分解代谢状态等)都会在非脂肪组织中诱导产生脂毒性状态,进而引发胰岛素抵抗。